Egnite
Egnite is a healthcare technology company specializing in AI-powered cardiovascular disease identification and management.
Profile
Egnite develops AI tools for cardiovascular disease identification and management.
Egnite is a healthcare technology company specializing in AI-powered cardiovascular disease identification and management. The company's CardioCare Platform is used by over 75 U.S. health systems, demonstrating significant adoption in the clinical space. Egnite has partnered with The Christ Health Network to deploy its Trial Accelerator tool, which expedites patient identification for clinical trials.
The company's focus on cardiovascular health positions it in a high-stakes segment of the healthcare market, where AI-driven diagnostics and management tools are increasingly critical. While specific financials and founding details are not publicly disclosed, Egnite's partnerships and customer base suggest a growing influence in the healthcare AI sector. Recent collaborations indicate a strategic push to integrate AI tools into clinical workflows, particularly for trial acceleration and disease management.
Who buys this
- U.S. health systems
- Clinical research organizations
- Hospitals and healthcare networks
- Cardiology departments
Publicly disclosed clients
- The Christ Health Network
Strengths and what to watch
Strengths
- CardioCare Platform adopted by over 75 U.S. health systems
- Strategic partnerships with major healthcare networks
- Focus on high-impact cardiovascular disease management
Watch for
- Limited public financial disclosures
- Dependence on healthcare provider adoption
- Competition from larger healthcare AI providers
Key Information
- Founded
- 2021
- Headquarters
- Seoul
Frequently Asked Questions
What does Egnite do in healthcare?
Egnite develops AI tools for cardiovascular disease identification and management. Their CardioCare Platform helps health systems detect and manage heart conditions, with adoption across 75+ U.S. providers. The company focuses on AI-driven diagnostics and trial acceleration partnerships like their Christ Health Network collaboration.
How widely is Egnite's CardioCare Platform used?
Egnite's CardioCare Platform is deployed in over 75 U.S. health systems, indicating strong clinical adoption. This AI solution assists cardiology departments and hospitals with cardiovascular disease management, though specific implementation details vary by healthcare network.
What is Egnite's Trial Accelerator tool?
Egnite's Trial Accelerator expedites patient identification for cardiovascular clinical trials. Developed in partnership with The Christ Health Network, this AI tool streamlines research workflows by matching eligible participants to appropriate studies faster than manual screening methods.
Which healthcare networks partner with Egnite?
The Christ Health Network is Egnite's notable partner, collaborating on the Trial Accelerator tool. While most clients are undisclosed, the company serves 75+ health systems through its CardioCare Platform for cardiovascular AI diagnostics and management solutions.
How does Egnite's AI help with heart disease?
Egnite's AI analyzes cardiovascular data to identify disease patterns and management opportunities. Their tools assist clinicians in detection, treatment planning, and trial matching—particularly valuable for time-sensitive cardiac conditions where early intervention improves outcomes.
Is Egnite's technology used in clinical research?
Yes, Egnite actively supports clinical research through tools like their Trial Accelerator. This AI solution helps research organizations and hospitals identify qualified participants for cardiovascular studies more efficiently than traditional screening methods.
Sources
- egnitehealth.com — Partnership with The Christ Health Network and Trial Accelerator tool
- egnitehealth.com — CardioCare Platform adoption by 75+ U.S. health systems